Sort
40,608 grants matching “prostate cancer”
Project 2: Arsenic as an Endocrine Disruptor
$367,899Joshua W Hamilton · Dartmouth College · P42 · FY2011 · ES
Active H+ Transport in Urinary Acidification
$367,877Columbia University Health Sciences · R01 · FY2005 · DK
Active H+ Transport in Urinary Acidification
$367,877Columbia University Health Sciences · R01 · FY2004 · DK
GSTP1 Promoter Hypermethylation In Human Prostate Cancer
$367,875Johns Hopkins University · R01 · FY2005 · CA
GSTP1 Promoter Hypermethylation In Human Prostate Cancer
$367,875Johns Hopkins University · R01 · FY2004 · CA
Methods for Bioactive Compound Synthesis
$367,871Paul R. Hanson · University Of Kansas Lawrence · R01 · FY2016 · GM
Project 2: Arsenic as an Endocrine Disruptor
$367,868Joshua W Hamilton · Dartmouth College · P42 · FY2012 · ES
P13K/PTEN/Akt signaling and the genesis of cancer
$367,867Nissim Hay · University Of Illinois At Chicago · R01 · FY2008 · CA
Regulation of prostate epithelial basal cell plasticity
$367,853Zhu Wang · University Of California Santa Cruz · R01 · FY2016 · GM
Regulation of prostate epithelial basal cell plasticity
$367,853Zhu Wang · University Of California Santa Cruz · R01 · FY2017 · GM
Regulation of prostate epithelial basal cell plasticity
$367,853Zhu Wang · University Of California Santa Cruz · R01 · FY2018 · GM
Regulation of prostate epithelial basal cell plasticity
$367,853Zhu Wang · University Of California Santa Cruz · R01 · FY2019 · GM
A ROLE OF MASPIN IN PROSTATE CANCER
$367,852Wayne State University · R01 · FY2003 · CA
Cancer Detection & Diagnosis Research-2022-Comprehensive genomic profiling of aggressive hormone sensitive prostate cancer
$367,841Christopher J Sweeney · University Of Adelaide · R01 · FY2023 · CA
Characterization of Prostate Cancer with 3T MR
$367,769Neil M Rofsky · Beth Israel Deaconess Medical Center · R01 · FY2007 · CA
The Six1/Eya Transcriptional complex as a mediator of lymphangiogenesis and lymph
$367,766Heide L Ford · University Of Colorado Denver · R01 · FY2012 · CA
p53 Fusion Protein as an Oncology Therapeutic
$367,754Xinli Henry Lin · Genecopoeia, Inc. · R44 · FY2010 · CA
p53 Fusion Protein as an Oncology Therapeutic
$367,754Xinli Henry Lin · Genecopoeia, Inc. · R44 · FY2009 · CA
TRANSGENIC MOUSE MODEL FOR PROSTATE CANCER
$367,682Vanderbilt University · R01 · FY2000 · CA
Investigations on the role of the CDK8 oncogene in colon cancer
$367,642William C Hahn · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Neural Mechanisms of Cancer Pain
$367,614Donald A Simone · University Of Minnesota · R01 · FY2022 · CA
REAL-TIME ROBOTIC IMAGE-GUIDED PROSTATE BRACHYTHERAPY
$367,550Burdette Medical Systems, Inc. · R44 · FY2002 · CA
Identifying and Reducing Disparities in Patient-Reported Outcomes Among African American Prostate Cancer Survivors
$367,549Brian D Gonzalez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
CANCER AND LEUKEMIA GROUP B--RPCI/SUNYAB
$367,544Roswell Park Cancer Institute Corp · U10 · FY2002 · CA
ATR Dependency as a Novel Therapeutic Target in Lethal RB Deficient ProstateCancer
$367,506Leigh Ellis · Cedars-Sinai Medical Center · R01 · FY2021 · CA